{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:51:16Z","timestamp":1792785076786,"version":"4.5.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["No.82403850"],"award-info":[{"award-number":["No.82403850"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Cross-Innovation Talent Project of Renmin Hospital of Wuhan University","award":["No. JCRCGW-2022-002"],"award-info":[{"award-number":["No. JCRCGW-2022-002"]}],"id":[{"id":"https:\/\/ror.org\/03ekhbz91","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01622-8","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:13:36Z","timestamp":1784967216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spatiotemporal multi-omics reveals lineage, spatial and functional heterogeneity of tumor-associated macrophages and therapeutic vulnerabilities in the tumor microenvironment"],"prefix":"10.1038","volume":"10","author":[{"given":"Taotao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchao","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"1622_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","volume":"19","author":"JJ Havel","year":"2019","unstructured":"Havel, J. J., Chowell, D. & Chan, T. A. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat. Rev. Cancer 19, 133\u2013150 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"1622_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","volume":"18","author":"H Jia","year":"2025","unstructured":"Jia, H., Chen, X., Zhang, L. & Chen, M. Cancer associated fibroblasts in cancer development and therapy. J. Hematol. Oncol. 18, 36 (2025).","journal-title":"J. Hematol. Oncol."},{"key":"1622_CR3","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo5570","volume":"10","author":"S Kumagai","year":"2025","unstructured":"Kumagai, S., Momoi, Y. & Nishikawa, H. Immunogenomic cancer evolution: A framework to understand cancer immunosuppression. Sci. Immunol. 10, eabo5570 (2025).","journal-title":"Sci. Immunol."},{"key":"1622_CR4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","volume":"81","author":"NR Anderson","year":"2021","unstructured":"Anderson, N. R., Minutolo, N. G., Gill, S. & Klichinsky, M. Macrophage-based approaches for cancer immunotherapy. Cancer Res. 81, 1201\u20131208 (2021).","journal-title":"Cancer Res."},{"key":"1622_CR5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell, B. & Coussens, L. M. Macrophages and therapeutic resistance in cancer. Cancer Cell 27, 462\u2013472 (2015).","journal-title":"Cancer Cell"},{"key":"1622_CR6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2005.10.001","volume":"23","author":"A Mantovani","year":"2005","unstructured":"Mantovani, A., Sica, A. & Locati, M. Macrophage polarization comes of age. Immunity 23, 344\u2013346 (2005).","journal-title":"Immunity"},{"key":"1622_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13072-025-00575-9","volume":"18","author":"K Zhang","year":"2025","unstructured":"Zhang, K. & Jagannath, C. Crosstalk between metabolism and epigenetics during macrophage polarization. Epigen. Chromatin 18, 16 (2025).","journal-title":"Epigen. Chromatin"},{"key":"1622_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41587-019-0392-8","volume":"38","author":"R Moncada","year":"2020","unstructured":"Moncada, R. et al. Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas. Nat. Biotechnol. 38, 333\u2013342 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1622_CR9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis, R. et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity 50, 1317\u20131334.e1310 (2019).","journal-title":"Immunity"},{"key":"1622_CR10","volume":"308","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. Single-cell and spatial analyses reveal the effect of VSIG4(+)S100A10(+)TAMs on the immunosuppression of glioblastoma and anti-PD-1 immunotherapy. Int J. Biol. Macromol. 308, 142415 (2025).","journal-title":"Int J. Biol. Macromol."},{"key":"1622_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12575-025-00270-9","volume":"27","author":"X Wan","year":"2025","unstructured":"Wan, X. et al. Tumor prognostic risk model related to monocytes\/macrophages in hepatocellular carcinoma based on machine learning and multi-omics. Biol. Proced. Online 27, 9 (2025).","journal-title":"Biol. Proced. Online"},{"key":"1622_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445\u2013455 (2013).","journal-title":"Nature"},{"key":"1622_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati, M., Curtale, G. & Mantovani, A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev. Pathol. 15, 123\u2013147 (2020).","journal-title":"Annu Rev. Pathol."},{"key":"1622_CR14","volume":"121","author":"HM Raquer-McKay","year":"2024","unstructured":"Raquer-McKay, H. M. et al. Monocytes give rise to Langerhans cells that preferentially migrate to lymph nodes at steady state. Proc. Natl. Acad. Sci. USA. 121, e2404927121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1622_CR15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-immunol-081022-113627","volume":"41","author":"LG Ng","year":"2023","unstructured":"Ng, L. G., Liu, Z., Kwok, I. & Ginhoux, F. Origin and heterogeneity of tissue myeloid cells: A focus on GMP-derived monocytes and neutrophils. Annu Rev. Immunol. 41, 375\u2013404 (2023).","journal-title":"Annu Rev. Immunol."},{"key":"1622_CR16","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nri3920","volume":"15","author":"Y Lavin","year":"2015","unstructured":"Lavin, Y., Mortha, A., Rahman, A. & Merad, M. Regulation of macrophage development and function in peripheral tissues. Nat. Rev. Immunol. 15, 731\u2013744 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1622_CR17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2019.01.010","volume":"176","author":"S De Schepper","year":"2019","unstructured":"De Schepper, S. et al. Self-maintaining gut macrophages are essential for intestinal homeostasis. Cell 176, 676 (2019).","journal-title":"Cell"},{"key":"1622_CR18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.kint.2023.04.023","volume":"104","author":"Q Zhu","year":"2023","unstructured":"Zhu, Q. et al. Self-maintaining macrophages within the kidney contribute to salt and water balance by modulating kidney sympathetic nerve activity. Kidney Int 104, 324\u2013333 (2023).","journal-title":"Kidney Int"},{"key":"1622_CR19","volume":"13","author":"N Li","year":"2022","unstructured":"Li, N. et al. Two distinct resident macrophage populations coexist in the ovary. Front Immunol. 13, 1007711 (2022).","journal-title":"Front Immunol."},{"key":"1622_CR20","volume":"208","author":"Y Gao","year":"2025","unstructured":"Gao, Y. et al. Metabolic cross-talk between glioblastoma and glioblastoma-associated microglia\/macrophages: From basic insights to therapeutic strategies. Crit. Rev. Oncol. Hematol. 208, 104649 (2025).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1622_CR21","volume":"2","author":"Y Xu","year":"2022","unstructured":"Xu, Y., Schrank, P. R. & Williams, J. W. Macrophage fate mapping. Curr. Protoc. 2, e456 (2022).","journal-title":"Curr. Protoc."},{"key":"1622_CR22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fonc.2020.00188","volume":"10","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. Tumor-associated macrophages: Recent insights and therapies. Front Oncol. 10, 188 (2020).","journal-title":"Front Oncol."},{"key":"1622_CR23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115332","volume":"220","author":"AF Karimova","year":"2025","unstructured":"Karimova, A. F. et al. Immunometabolism of tumor-associated macrophages: A therapeutic perspective. Eur. J. Cancer 220, 115332 (2025).","journal-title":"Eur. J. Cancer"},{"key":"1622_CR24","volume":"13","author":"J Chi","year":"2024","unstructured":"Chi, J., Gao, Q. & Liu, D. Tissue-resident macrophages in cancer: Friend or foe? Cancer Med. 13, e70387 (2024).","journal-title":"Cancer Med"},{"key":"1622_CR25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","volume":"10","author":"F Guan","year":"2025","unstructured":"Guan, F. et al. Tissue macrophages: Origin, heterogenity, biological functions, diseases and therapeutic targets. Signal Transduct. Target Ther. 10, 93 (2025).","journal-title":"Signal Transduct. Target Ther."},{"key":"1622_CR26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.immuni.2017.07.014","volume":"47","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y. et al. Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression. Immunity 47, 323\u2013338.e326 (2017).","journal-title":"Immunity"},{"key":"1622_CR27","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1252510","volume":"344","author":"RA Franklin","year":"2014","unstructured":"Franklin, R. A. et al. The cellular and molecular origin of tumor-associated macrophages. Science 344, 921\u2013925 (2014).","journal-title":"Science"},{"key":"1622_CR28","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder, K. et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity 54, 1883\u20131900.e1885 (2021).","journal-title":"Immunity"},{"key":"1622_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Tumor-associated macrophages: An accomplice in solid tumor progression. J. Biomed. Sci. 26, 78 (2019).","journal-title":"J. Biomed. Sci."},{"key":"1622_CR30","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","volume":"169","author":"Y Lavin","year":"2017","unstructured":"Lavin, Y. et al. Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell 169, 750\u2013765.e717 (2017).","journal-title":"Cell"},{"key":"1622_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin, Y., Xu, J. & Lan, H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J. Hematol. Oncol. 12, 76 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"1622_CR32","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.2147\/JIR.S493656","volume":"17","author":"S Li","year":"2024","unstructured":"Li, S., Hao, L. & Hu, X. Biological roles and clinical therapeutic applications of tumor-associated macrophages in colorectal liver metastasis. J. Inflamm. Res. 17, 8429\u20138443 (2024).","journal-title":"J. Inflamm. Res."},{"key":"1622_CR33","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293\u20131308.e1236 (2018).","journal-title":"Cell"},{"key":"1622_CR34","volume":"11","author":"D Liu","year":"2024","unstructured":"Liu, D. et al. Multi-omics analysis reveals the landscape of tumor microenvironments in left-sided and right-sided colon cancer. Front Med. (Lausanne) 11, 1403171 (2024).","journal-title":"Front Med. (Lausanne)"},{"key":"1622_CR35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179, 829\u2013845.e820 (2019).","journal-title":"Cell"},{"key":"1622_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03574-0","volume":"24","author":"Z Yin","year":"2024","unstructured":"Yin, Z., Song, Y. & Wang, L. Single-cell RNA sequencing reveals the landscape of the cellular ecosystem of primary hepatocellular carcinoma. Cancer Cell Int. 24, 379 (2024).","journal-title":"Cancer Cell Int."},{"key":"1622_CR37","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/1759-7714.15283","volume":"15","author":"L Shen","year":"2024","unstructured":"Shen, L. et al. Single-cell RNA sequencing reveals aberrant sphingolipid metabolism in non-small cell lung cancer impacts tumor-associated macrophages and stimulates angiogenesis via macrophage inhibitory factor signaling. Thorac. Cancer 15, 1164\u20131175 (2024).","journal-title":"Thorac. Cancer"},{"key":"1622_CR38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1053\/j.gastro.2025.01.244","volume":"168","author":"D Yang","year":"2025","unstructured":"Yang, D. et al. TREM2 depletion in pancreatic cancer elicits pathogenic inflammation and accelerates tumor progression via enriching IL-1beta(+) macrophages. Gastroenterology 168, 1153\u20131169 (2025).","journal-title":"Gastroenterology"},{"key":"1622_CR39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"RY Ma","year":"2022","unstructured":"Ma, R. Y., Black, A. & Qian, B. Z. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 43, 546\u2013563 (2022).","journal-title":"Trends Immunol."},{"key":"1622_CR40","volume":"15","author":"H Jin","year":"2024","unstructured":"Jin, H. et al. Identification of SPP1 (+) macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics. Front Immunol. 15, 1446453 (2024).","journal-title":"Front Immunol."},{"key":"1622_CR41","volume":"15","author":"B Li","year":"2024","unstructured":"Li, B., Hu, J. & Xu, H. Integrated single-cell and bulk RNA sequencing reveals immune-related SPP1+ macrophages as a potential strategy for predicting the prognosis and treatment of liver fibrosis and hepatocellular carcinoma. Front Immunol. 15, 1455383 (2024).","journal-title":"Front Immunol."},{"key":"1622_CR42","volume":"604","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Identification of SPP1(+) macrophages in promoting cancer stemness via vitronectin and CCL15 signals crosstalk in liver cancer. Cancer Lett. 604, 217199 (2024).","journal-title":"Cancer Lett."},{"key":"1622_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52977-0","volume":"15","author":"Z Yang","year":"2024","unstructured":"Yang, Z. et al. Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma. Nat. Commun. 15, 9097 (2024).","journal-title":"Nat. Commun."},{"key":"1622_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03750-w","volume":"25","author":"Q Wang","year":"2025","unstructured":"Wang, Q. et al. Integrated single-cell and bulk transcriptomic analysis identifies a novel macrophage subtype associated with poor prognosis in breast cancer. Cancer Cell Int. 25, 119 (2025).","journal-title":"Cancer Cell Int"},{"key":"1622_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02301-1","volume":"24","author":"X Su","year":"2025","unstructured":"Su, X., Liang, C., Chen, R. & Duan, S. Correction: Deciphering tumor microenvironment: CXCL9 and SPP1 as crucial determinants of tumor-associated macrophage polarity and prognostic indicators. Mol. Cancer 24, 87 (2025).","journal-title":"Mol. Cancer"},{"key":"1622_CR46","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","volume":"182","author":"M Molgora","year":"2020","unstructured":"Molgora, M. et al. TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy. Cell 182, 886\u2013900.e817 (2020).","journal-title":"Cell"},{"key":"1622_CR47","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.trecan.2025.02.006","volume":"11","author":"CFA Ramirez","year":"2025","unstructured":"Ramirez, C. F. A. & Akkari, L. Myeloid cell path to malignancy: Insights into liver cancer. Trends Cancer 11, 591\u2013610 (2025).","journal-title":"Trends Cancer"},{"key":"1622_CR48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/cas.16436","volume":"116","author":"T Lyu","year":"2025","unstructured":"Lyu, T. et al. Single-cell RNA sequencing reveals the tumor heterogeneity and immunosuppressive microenvironment in urothelial carcinoma. Cancer Sci. 116, 710\u2013723 (2025).","journal-title":"Cancer Sci."},{"key":"1622_CR49","volume":"12","author":"Z Xie","year":"2025","unstructured":"Xie, Z. et al. SPP1 (+) macrophages in colorectal cancer: Markers of malignancy and promising therapeutic targets. Genes Dis. 12, 101340 (2025).","journal-title":"Genes Dis."},{"key":"1622_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93584-3","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Unveiling the role of PPIF and macrophage subtypes in LSCC progression via single-cell and exosome RNA sequencing. Sci. Rep. 15, 10141 (2025).","journal-title":"Sci. Rep."},{"key":"1622_CR51","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","volume":"70","author":"AL Doedens","year":"2010","unstructured":"Doedens, A. L. et al. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res 70, 7465\u20137475 (2010).","journal-title":"Cancer Res"},{"key":"1622_CR52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","volume":"17","author":"X Mu","year":"2018","unstructured":"Mu, X. et al. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer. Cell Cycle 17, 428\u2013438 (2018).","journal-title":"Cell Cycle"},{"key":"1622_CR53","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1111\/febs.70081","volume":"292","author":"J Petiti","year":"2025","unstructured":"Petiti, J., Arpinati, L., Menga, A. & Carra, G. The influence of fatty acid metabolism on T cell function in lung cancer. FEBS J. 292, 3596\u20133615 (2025).","journal-title":"FEBS J."},{"key":"1622_CR54","first-page":"7","volume":"8","author":"C Suri","year":"2025","unstructured":"Suri, C. et al. Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance. Cancer Drug Resist 8, 7 (2025).","journal-title":"Cancer Drug Resist"},{"key":"1622_CR55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","volume":"6","author":"Z Duan","year":"2021","unstructured":"Duan, Z. & Luo, Y. Targeting macrophages in cancer immunotherapy. Signal Transduct. Target. Ther. 6, 127 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1622_CR56","doi-asserted-by":"crossref","first-page":"1596004","DOI":"10.1080\/2162402X.2019.1596004","volume":"8","author":"I Larionova","year":"2019","unstructured":"Larionova, I. et al. Interaction of tumor-associated macrophages and cancer chemotherapy. Oncoimmunology 8, 1596004 (2019).","journal-title":"Oncoimmunology"},{"key":"1622_CR57","volume":"24","author":"S Guo","year":"2022","unstructured":"Guo, S., Chen, X., Guo, C. & Wang, W. Tumour-associated macrophages heterogeneity drives resistance to clinical therapy. Expert Rev. Mol. Med. 24, e17 (2022).","journal-title":"Expert Rev. Mol. Med."},{"key":"1622_CR58","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1084\/jem.20150295","volume":"212","author":"A Mantovani","year":"2015","unstructured":"Mantovani, A. & Allavena, P. The interaction of anticancer therapies with tumor-associated macrophages. J. Exp. Med. 212, 435\u2013445 (2015).","journal-title":"J. Exp. Med."},{"key":"1622_CR59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw7843","volume":"12","author":"L Akkari","year":"2020","unstructured":"Akkari, L. et al. Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance. Sci. Transl. Med. 12, eaaw7843 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1622_CR60","doi-asserted-by":"crossref","unstructured":"Schmittnaegel, M. et al. Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade. Sci. Transl. Med. 9, eaak9670 (2017).","DOI":"10.1126\/scitranslmed.aak9670"},{"key":"1622_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban, R. et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun. Signal 18, 59 (2020).","journal-title":"Cell Commun. Signal"},{"key":"1622_CR62","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41417-021-00318-4","volume":"28","author":"Q Ping","year":"2021","unstructured":"Ping, Q. et al. Cancer-associated fibroblasts: Overview, progress, challenges, and directions. Cancer Gene Ther. 28, 984\u2013999 (2021).","journal-title":"Cancer Gene Ther."},{"key":"1622_CR63","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.devcel.2017.11.003","volume":"43","author":"M Roh-Johnson","year":"2017","unstructured":"Roh-Johnson, M. et al. Macrophage-dependent cytoplasmic transfer during melanoma invasion in vivo. Dev. Cell 43, 549\u2013562.e546 (2017).","journal-title":"Dev. Cell"},{"key":"1622_CR64","doi-asserted-by":"crossref","unstructured":"Luo, S. et al. Macrophages are a double-edged sword: molecular crosstalk between tumor-associated macrophages and cancer stem cells. Biomolecules, 12, 850 (2022).","DOI":"10.3390\/biom12060850"},{"key":"1622_CR65","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature13988","volume":"515","author":"MM Gubin","year":"2014","unstructured":"Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577\u2013581 (2014).","journal-title":"Nature"},{"key":"1622_CR66","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1172\/JCI97642","volume":"129","author":"D Muraoka","year":"2019","unstructured":"Muraoka, D. et al. Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance. J. Clin. Invest 129, 1278\u20131294 (2019).","journal-title":"J. Clin. Invest"},{"key":"1622_CR67","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","volume":"181","author":"E Friebel","year":"2020","unstructured":"Friebel, E. et al. Single-cell mapping of human brain cancer reveals tumor-specific instruction of tissue-invading leukocytes. Cell 181, 1626\u20131642.e1620 (2020).","journal-title":"Cell"},{"key":"1622_CR68","doi-asserted-by":"crossref","unstructured":"Takahashi, H., Perez-Villarroel, P., Falahat, R., Mule, J. J. Targeting MARCO in combination with anti-CTLA-4 leads to enhanced melanoma regression and immune cell infiltration via macrophage reprogramming. J. Immunother. Cancer, 13, e011030 (2025).","DOI":"10.1136\/jitc-2024-011030"},{"key":"1622_CR69","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442\u2013459.e429 (2020).","journal-title":"Cell"},{"key":"1622_CR70","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1158\/2159-8290.CD-20-0841","volume":"11","author":"SM Liudahl","year":"2021","unstructured":"Liudahl, S. M. et al. Leukocyte heterogeneity in pancreatic ductal adenocarcinoma: phenotypic and spatial features associated with clinical outcome. Cancer Discov. 11, 2014\u20132031 (2021).","journal-title":"Cancer Discov."},{"key":"1622_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62668-x","volume":"14","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Multi-omics analysis of macrophage-associated receptor and ligand reveals a strong prognostic signature and subtypes in hepatocellular carcinoma. Sci. Rep. 14, 12163 (2024).","journal-title":"Sci. Rep."},{"key":"1622_CR72","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"1622_CR73","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1101\/gr.240663.118","volume":"29","author":"L Garcia-Alonso","year":"2019","unstructured":"Garcia-Alonso, L., Holland, C. H., Ibrahim, M. M., Turei, D. & Saez-Rodriguez, J. Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res 29, 1363\u20131375 (2019).","journal-title":"Genome Res"},{"key":"1622_CR74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2019.194431","volume":"1863","author":"CH Holland","year":"2020","unstructured":"Holland, C. H., Szalai, B. & Saez-Rodriguez, J. Transfer of regulatory knowledge from human to mouse for functional genomics analysis. Biochim Biophys. Acta Gene Regul. Mech. 1863, 194431 (2020).","journal-title":"Biochim Biophys. Acta Gene Regul. Mech."},{"key":"1622_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01669-6","volume":"25","author":"C Yang","year":"2023","unstructured":"Yang, C. et al. Infiltrating myeloid cell diversity determines oncological characteristics and clinical outcomes in breast cancer. Breast Cancer Res 25, 63 (2023).","journal-title":"Breast Cancer Res"},{"key":"1622_CR76","volume":"14","author":"Z Huang","year":"2023","unstructured":"Huang, Z. et al. Integrated analyses of single-cell transcriptomics identify metastasis-associated myeloid subpopulations in breast cancer lung metastasis. Front Immunol. 14, 1180402 (2023).","journal-title":"Front Immunol."},{"key":"1622_CR77","volume":"15","author":"SM Park","year":"2024","unstructured":"Park, S. M. et al. Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors. Front Immunol. 15, 1412076 (2024).","journal-title":"Front Immunol."},{"key":"1622_CR78","volume":"13","author":"Y Xi","year":"2023","unstructured":"Xi, Y. et al. A chemotherapy response prediction model derived from tumor-promoting B and Tregs and proinflammatory macrophages in HGSOC. Front Oncol. 13, 1171582 (2023).","journal-title":"Front Oncol."},{"key":"1622_CR79","doi-asserted-by":"crossref","unstructured":"Xie, Y., Yang, J., Ouyang, J. F., Petretto, E. scPanel: A tool for automatic identification of sparse gene panels for generalizable patient classification using scRNA-seq datasets. Brief Bioinform, 25, bbae482 (2024).","DOI":"10.1093\/bib\/bbae482"},{"key":"1622_CR80","volume":"9","author":"T Hui","year":"2025","unstructured":"Hui, T., Zhou, J., Yao, M., Xie, Y. & Zeng, H. Advances in spatial omics technologies. Small Methods 9, e2401171 (2025).","journal-title":"Small Methods"},{"key":"1622_CR81","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41587-020-0739-1","volume":"39","author":"RR Stickels","year":"2021","unstructured":"Stickels, R. R. et al. Highly sensitive spatial transcriptomics at near-cellular resolution with Slide-seqV2. Nat. Biotechnol. 39, 313\u2013319 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1622_CR82","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae546","volume":"40","author":"K Pola\u0144ski","year":"2024","unstructured":"Pola\u0144ski, K. et al. Bin2cell reconstructs cells from high resolution Visium HD data. Bioinformatics 40, btae546 (2024).","journal-title":"Bioinformatics"},{"key":"1622_CR83","volume":"348","author":"KH Chen","year":"2015","unstructured":"Chen, K. H., Boettiger, A. N., Moffitt, J. R., Wang, S. & Zhuang, X. RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells. Science 348, aaa6090 (2015).","journal-title":"Science"},{"key":"1622_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51708-9","volume":"15","author":"J Jiang","year":"2024","unstructured":"Jiang, J. et al. METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics. Nat. Commun. 15, 7312 (2024).","journal-title":"Nat. Commun."},{"key":"1622_CR85","doi-asserted-by":"crossref","unstructured":"Pratt, H. G. et al. Macrophage and neutrophil interactions in the pancreatic tumor microenvironment drive the pathogenesis of pancreatic cancer. Cancers (Basel), 14, 194 (2021).","DOI":"10.3390\/cancers14010194"},{"key":"1622_CR86","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fphys.2014.00075","volume":"5","author":"V Riabov","year":"2014","unstructured":"Riabov, V. et al. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol. 5, 75 (2014).","journal-title":"Front Physiol."},{"key":"1622_CR87","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","volume":"42","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. Cancer Cell 42, 815\u2013832.e812 (2024).","journal-title":"Cancer Cell"},{"key":"1622_CR88","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","volume":"608","author":"C Kuppe","year":"2022","unstructured":"Kuppe, C. et al. Spatial multi-omic map of human myocardial infarction. Nature 608, 766\u2013777 (2022).","journal-title":"Nature"},{"key":"1622_CR89","doi-asserted-by":"crossref","unstructured":"Khantakova D., Brioschi S., Molgora M. Exploring the impact of TREM2 in tumor-associated macrophages. Vaccines (Basel), 10 (2022).","DOI":"10.3390\/vaccines10060943"},{"key":"1622_CR90","doi-asserted-by":"crossref","unstructured":"Zhang, H. et al. Spatially resolved C1QC+ macrophage-CD4+ T cell niche in colorectal cancer microenvironment: implications for immunotherapy response. Cell Discovery, 11, 60 (2025).","DOI":"10.1038\/s41421-025-00811-2"},{"key":"1622_CR91","volume":"16","author":"Y Xin","year":"2025","unstructured":"Xin, Y. et al. Analysis of single-cell and spatial transcriptomics in TNBC cell-cell interactions. Front Immunol. 16, 1521388 (2025).","journal-title":"Front Immunol."},{"key":"1622_CR92","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1158\/1078-0432.CCR-24-1690","volume":"30","author":"E Timperi","year":"2024","unstructured":"Timperi, E. et al. At the interface of tumor-associated macrophages and fibroblasts: Immune-suppressive networks and emerging exploitable targets. Clin. Cancer Res 30, 5242\u20135251 (2024).","journal-title":"Clin. Cancer Res"},{"key":"1622_CR93","volume":"15","author":"J Yan","year":"2025","unstructured":"Yan, J. et al. Spatial\u2012temporal heterogeneities of liver cancer and the discovery of the invasive zone. Clin. Transl. Med. 15, e70224 (2025).","journal-title":"Clin. Transl. Med."},{"key":"1622_CR94","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10555-021-09958-2","volume":"40","author":"V Delprat","year":"2021","unstructured":"Delprat, V. & Michiels, C. A bi-directional dialog between vascular cells and monocytes\/macrophages regulates tumor progression. Cancer Metastasis Rev. 40, 477\u2013500 (2021).","journal-title":"Cancer Metastasis Rev."},{"key":"1622_CR95","doi-asserted-by":"crossref","unstructured":"Xu, W. et al. Spatial immune remodeling of the liver metastases: Discovering the path to antimetastatic therapy. J. Immunother Cancer, 13, e011002 (2025).","DOI":"10.1136\/jitc-2024-011002"},{"key":"1622_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06186-y","volume":"23","author":"VY Naei","year":"2025","unstructured":"Naei, V. Y. et al. Spatial interaction mapping of PD-1\/PD-L1 in head and neck cancer reveals the role of macrophage-tumour barriers associated with immunotherapy response. J. Transl. Med. 23, 177 (2025).","journal-title":"J. Transl. Med"},{"key":"1622_CR97","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.it.2025.03.001","volume":"46","author":"N Caronni","year":"2025","unstructured":"Caronni, N., La Terza, F., Frosio, L. & Ostuni, R. IL-1beta(+) macrophages and the control of pathogenic inflammation in cancer. Trends Immunol. 46, 403\u2013415 (2025).","journal-title":"Trends Immunol."},{"key":"1622_CR98","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.2147\/JIR.S509245","volume":"18","author":"S Yang","year":"2025","unstructured":"Yang, S. et al. The role of PLIN3 in prognosis and tumor-associated macrophage infiltration: A pan-cancer analysis. J. Inflamm. Res 18, 3757\u20133777 (2025).","journal-title":"J. Inflamm. Res"},{"key":"1622_CR99","volume":"161","author":"J Xu","year":"2025","unstructured":"Xu, J. et al. Tumor-associated macrophages in radiotherapy: Mechanisms of polarization, immune regulation and therapeutic strategies. Int. Immunopharmacol. 161, 115009 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"1622_CR100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/cac2.70016","volume":"45","author":"R Zhao","year":"2025","unstructured":"Zhao, R. et al. Blocking ITGA5 potentiates the efficacy of anti-PD-1 therapy on glioblastoma by remodeling tumor-associated macrophages. Cancer Commun. (Lond.) 45, 677\u2013701 (2025).","journal-title":"Cancer Commun. (Lond.)"},{"key":"1622_CR101","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5582\/bst.2024.01372","volume":"18","author":"H Hakoda","year":"2025","unstructured":"Hakoda, H., Ichida, A. & Hasegawa, K. Advances in systemic therapy leading to conversion surgery for advanced hepatocellular carcinoma. Biosci. Trends 18, 525\u2013534 (2025).","journal-title":"Biosci. Trends"},{"key":"1622_CR102","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5582\/bst.2024.01156","volume":"18","author":"H Momose","year":"2024","unstructured":"Momose, H. et al. Trends in the treatment of advanced pancreatic cancer. Biosci. Trends 18, 224\u2013232 (2024).","journal-title":"Biosci. Trends"},{"key":"1622_CR103","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1158\/1535-7163.MCT-16-0124","volume":"16","author":"KY Teng","year":"2017","unstructured":"Teng, K. Y. et al. Blocking the CCL2-CCR2 axis using CCL2-neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse model. Mol. Cancer Ther. 16, 312\u2013322 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"1622_CR104","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.7150\/ijbs.106275","volume":"21","author":"H Tan","year":"2025","unstructured":"Tan, H. et al. Harnessing macrophages in cancer therapy: From immune modulators to therapeutic targets. Int. J. Biol. Sci. 21, 2235\u20132257 (2025).","journal-title":"Int. J. Biol. Sci."},{"key":"1622_CR105","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1016\/j.cell.2025.08.013","volume":"188","author":"Y Han","year":"2025","unstructured":"Han, Y. et al. Tumors hijack macrophages for iron supply to promote bone metastasis and anemia. Cell 188, 6335\u20136354.e6326 (2025).","journal-title":"Cell"},{"key":"1622_CR106","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.cmet.2025.08.009","volume":"37","author":"Y Xiao","year":"2025","unstructured":"Xiao, Y. et al. HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer. Cell Metab. 37, 2030\u20132047.e2037 (2025).","journal-title":"Cell Metab."},{"key":"1622_CR107","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2024.09.029","volume":"82","author":"X Yang","year":"2025","unstructured":"Yang, X. et al. FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity. J. Hepatol. 82, 676\u2013689 (2025).","journal-title":"J. Hepatol."},{"key":"1622_CR108","doi-asserted-by":"crossref","unstructured":"Chen J, Mo J, Wei J, et al. MARCO+ Tumor-Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell Carcinoma. Adv Sci (Weinh). 12, e14600 (2025).","DOI":"10.1002\/advs.202514600"},{"key":"1622_CR109","doi-asserted-by":"crossref","unstructured":"Hu, L., Wang, X., Song, Z., Chen, F., Wu, B. Leveraging CAR macrophages targeting c-Met for precision immunotherapy in pancreatic cancer: Insights from single-cell multi-omics. Mol. Med. 30, 231 (2024).","DOI":"10.1186\/s10020-024-00996-4"},{"key":"1622_CR110","doi-asserted-by":"crossref","unstructured":"Jumaniyazova, E. et al. The role of macrophages in various types of tumors and the possibility of their use as targets for antitumor therapy. Cancers (Basel) 17, 342 (2025).","DOI":"10.3390\/cancers17030342"},{"key":"1622_CR111","volume":"13","author":"H Peng","year":"2023","unstructured":"Peng, H. et al. Multiplex immunofluorescence and single-cell transcriptomic profiling reveal the spatial cell interaction networks in the non-small cell lung cancer microenvironment. Clin. Transl. Med. 13, e1155 (2023).","journal-title":"Clin. Transl. Med."},{"key":"1622_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40271-4","volume":"14","author":"R Arora","year":"2023","unstructured":"Arora, R. et al. Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response. Nat. Commun. 14, 5029 (2023).","journal-title":"Nat. Commun."},{"key":"1622_CR113","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ccell.2024.06.009","volume":"42","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer. Cancer Cell 42, 1268\u20131285.e1267 (2024).","journal-title":"Cancer Cell"},{"key":"1622_CR114","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ccell.2025.02.009","volume":"43","author":"J Chang","year":"2025","unstructured":"Chang, J. et al. Single-cell multi-stage spatial evolutional map of esophageal carcinogenesis. Cancer Cell 43, 380\u2013397.e387 (2025).","journal-title":"Cancer Cell"},{"key":"1622_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59878-w","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Dynamic single-cell metabolomics reveals cell-cell interaction between tumor cells and macrophages. Nat. Commun. 16, 4582 (2025).","journal-title":"Nat. Commun."},{"key":"1622_CR116","doi-asserted-by":"crossref","first-page":"14935","DOI":"10.1021\/acs.analchem.4c02989","volume":"96","author":"X Hu","year":"2024","unstructured":"Hu, X. et al. Polarization of Macrophages in Tumor Microenvironment Using High-Throughput Single-Cell Metabolomics. Anal. Chem. 96, 14935\u201314943 (2024).","journal-title":"Anal. Chem."},{"key":"1622_CR117","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"1622_CR118","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","volume":"80","author":"P Su","year":"2020","unstructured":"Su, P. et al. Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages. Cancer Res. 80, 1438\u20131450 (2020).","journal-title":"Cancer Res."},{"key":"1622_CR119","doi-asserted-by":"crossref","unstructured":"Li, S. et al. Metabolism drives macrophage heterogeneity in the tumor microenvironment. Cell Rep. 39, 2022;39(1):110609.","DOI":"10.1016\/j.celrep.2022.110609"},{"key":"1622_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02240-x","volume":"24","author":"X Xu","year":"2025","unstructured":"Xu, X. et al. From morphology to single-cell molecules: High-resolution 3D histology in biomedicine. Mol. Cancer 24, 63 (2025).","journal-title":"Mol. Cancer"},{"key":"1622_CR121","doi-asserted-by":"crossref","unstructured":"Liang, S., et al. SURF: A self-supervised deep learning method for reference-free deconvolution in spatial transcriptomics. Adv. Sci. 12, e05456 (2025).","DOI":"10.1002\/advs.202505456"},{"key":"1622_CR122","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809.e723 (2021).","journal-title":"Cell"},{"key":"1622_CR123","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ccell.2025.01.012","volume":"43","author":"H Chen","year":"2025","unstructured":"Chen, H. et al. Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer. Cancer Cell 43, 519\u2013536.e515 (2025).","journal-title":"Cancer Cell"},{"key":"1622_CR124","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1021\/acs.molpharmaceut.4c01277","volume":"22","author":"X Cao","year":"2025","unstructured":"Cao, X. et al. Antitumor research based on drug delivery carriers: Reversing the polarization of tumor-associated macrophages. Mol. Pharm. 22, 1174\u20131197 (2025).","journal-title":"Mol. Pharm."},{"key":"1622_CR125","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s10147-017-1161-7","volume":"22","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. PD-L1 induced by IFN-\u03b3 from tumor-associated macrophages via the JAK\/STAT3 and PI3K\/AKT signaling pathways promoted progression of lung cancer. Int. J. Clin. Oncol. 22, 1026\u20131033 (2017).","journal-title":"Int. J. Clin. Oncol."},{"key":"1622_CR126","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R. & Pollard, J. W. Tumor-associated macrophages: From mechanisms to therapy. Immunity 41, 49\u201361 (2014).","journal-title":"Immunity"},{"key":"1622_CR127","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","volume":"623","author":"N Caronni","year":"2023","unstructured":"Caronni, N. et al. IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer. Nature 623, 415\u2013422 (2023).","journal-title":"Nature"},{"key":"1622_CR128","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/0008-5472.CAN-22-1427","volume":"82","author":"E Timperi","year":"2022","unstructured":"Timperi, E. et al. Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer. Cancer Res. 82, 3291\u20133306 (2022).","journal-title":"Cancer Res."},{"key":"1622_CR129","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12072-023-10615-9","volume":"18","author":"C-L Yang","year":"2024","unstructured":"Yang, C.-L. et al. Integrating single-cell and bulk RNA sequencing reveals CK19\u2009+\u2009cancer stem cells and their specific SPP1\u2009+\u2009tumor-associated macrophage niche in HBV-related hepatocellular carcinoma. Hepatol. Int. 18, 73\u201390 (2024).","journal-title":"Hepatol. Int."},{"key":"1622_CR130","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cell.2022.02.021","volume":"185","author":"R Nalio Ramos","year":"2022","unstructured":"Nalio Ramos, R. et al. Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer. Cell 185, 1189\u20131207.e1125 (2022).","journal-title":"Cell"},{"key":"1622_CR131","doi-asserted-by":"crossref","first-page":"101340","DOI":"10.1016\/j.gendis.2024.101340","volume":"12","author":"Z Xie","year":"2025","unstructured":"Xie, Z. et al. SPP1+ macrophages in colorectal cancer: Markers of malignancy and promising therapeutic targets. Genes Dis. 12, 101340 (2025).","journal-title":"Genes Dis."},{"key":"1622_CR132","volume":"12","author":"Y Luo","year":"2025","unstructured":"Luo, Y. et al. RUNX1\/SLAMF3 axis drives immunosuppression to contribute to colorectal cancer liver metastasis by blocking phagocytosis and depleting C1QC(+) tumor-associated macrophages. Adv. Sci. (Weinh.) 12, e06641 (2025).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"1622_CR133","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s13402-020-00549-x","volume":"43","author":"C Tekin","year":"2020","unstructured":"Tekin, C. et al. Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation. Cell Oncol. (Dordr.) 43, 1161\u20131174 (2020).","journal-title":"Cell Oncol. (Dordr.)"},{"key":"1622_CR134","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.31545","volume":"143","author":"L La Fleur","year":"2018","unstructured":"La Fleur, L. et al. Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer. Int. J. Cancer 143, 1741\u20131752 (2018).","journal-title":"Int. J. Cancer"},{"key":"1622_CR135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ccell.2025.11.009","volume":"44","author":"G Yagel","year":"2026","unstructured":"Yagel, G. et al. Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells. Cancer Cell 44, 519\u2013533.e510 (2026).","journal-title":"Cancer Cell"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01622-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01622-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01622-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:39:39Z","timestamp":1792093179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01622-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1622"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01622-8","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"393"}}